Chemours profit margin CC
Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.
- Net margin, 12 months
- −5.2%
- Net margin on a year earlier
- +2.1 pts
- Peer median
- 6.1%
Over the twelve months to Jun 30, 2026, Chemours kept −5.2% of its revenue as net profit.
Five years earlier its net margin was 4.5%.
The median for 10 chemicals stocks of a similar size is 6.1%.
Profit margin over time
GrossOperatingNet
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −6.6% | n/a | n/a |
| FY2024 | 1.2% | 4.5% | 19.8% |
| FY2023 | −3.9% | −4.2% | 21.5% |
| FY2022 | 8.5% | 11.4% | 23.8% |
| FY2021 | 9.6% | 10.6% | 21.8% |
| FY2020 | 4.4% | 7.4% | 21.5% |
| FY2019 | −0.9% | 6.3% | 19.2% |
| FY2018 | 15.0% | 17.8% | 29.7% |
| FY2017 | 12.1% | 15.8% | 28.2% |
| FY2016 | 0.1% | −1.4% | 20.6% |
| FY2015 | −1.6% | −2.3% | 16.7% |
| FY2014 | 6.2% | 7.9% | 21.1% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −5.2% | +2.1 pts | n/a | |
| Q1 FY26 | −7.0% | −7.3 pts | n/a | |
| Q4 FY25 | −6.6% | −7.9 pts | n/a | |
| Q3 FY25 | −6.0% | −7.1 pts | −0.8% | |
| Q2 FY25 | −7.3% | −9.2 pts | −2.0% | |
| Q1 FY25 | 0.2% | +5.8 pts | 3.4% | |
| Q4 FY24 | 1.2% | +5.1 pts | 4.5% | |
| Q3 FY24 | 1.1% | +6.3 pts | 4.4% | |
| Q2 FY24 | 1.9% | +3.3 pts | 4.3% | |
| Q1 FY24 | −5.6% | −13.0 pts | −5.3% | |
| Q4 FY23 | −3.9% | −12.4 pts | −4.2% | |
| Q3 FY23 | −5.2% | −18.1 pts | −4.2% |
Against its peers
Companies in Chemicals nearest Chemours' size, closest first, today.
| Company | Profit margin |
|---|---|
| CCChemours | −5.2% |
| ROGRogers | 3.7% |
| NGVTIngevity | 4.7% |
| IOSPInnospec | 6.6% |
| FULFuller H B | 5.6% |
| WDFCWD 40 | 13.2% |
| CRONCronos | 39.1% |
| AVNTAvient | 5.1% |
| CBTCabot | 5.2% |
| FTKFlotek Industries | 13.0% |
| CSWCSW Industrials | 10.3% |
| Peer median | 6.1% |
Where Chemours ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Chemours
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.